|
Cours en clôture
Shenzhen S.E.
23/07/2026
|
Varia. 5j.
|
Varia. 1 janv.
|
|
4,700 CNY
|
+0,86%
|
 |
-4,08%
|
-9,96%
|
|
15/06 |
Northeast Pharmaceutical Group Co., Ltd. Announces Final Cash Dividend on A Shares for 2025, Payable on 23 June 2026
| | |
27/04 |
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026
| | |
02/04 |
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025
| | |
02/04 |
Northeast Pharmaceutical Group Co., Ltd. announces Annual dividend, payable on June 23, 2026
| | |
27/10/25 |
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
| | |
09/10/25 |
Northeast Pharmaceutical Unit Gets Clinical Trial Approval for Glioma Treatment
| | |
08/09/25 |
Northeast Pharmaceutical Appoints CFO
| | |
02/09/25 |
Northeast Pharmaceutical CFO Resigns
| | |
26/08/25 |
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
| | |
05/06/25 |
Northeast Pharmaceutical Gets Nod to Market Antiobiotic in Europe
| | |
28/04/25 |
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025
| | |
25/04/25 |
Northeast Pharmaceutical Group Co., Ltd. Announces Directorate Appointments
| | |
25/04/25 |
Northeast Pharmaceutical Group Co., Ltd. Approves Cash Dividend on (A Shares) for 2024, Payable on 23 June 2025
| | |
17/04/25 |
Northeast Pharmaceutical's Subsidiary Gets Nod to Market Levocarnitine Oral Solution
| | |
03/04/25 |
Northeast Pharmaceutical Group Co., Ltd. Proposes Final Cash Dividend for the Year 2024
| | |
02/04/25 |
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024
| | |
17/02/25 |
Northeast Pharmaceutical Gets Nod to Market HIV Raw Drug Material
| | |
22/01/25 |
Northeast Pharmaceutical Group Names Chair
| | |
09/01/25 |
Northeast Pharma to Donate 10 Million Yuan in Goods to Tibet's Earthquake Victims
| | |
19/12/24 |
Northeast Pharmaceutical Gets Nod to Market Empagliflozin
| | |
19/11/24 |
Northeast Pharmaceutical Group Co., Ltd. Completed the acquisition of 70% stake in Beijing Dingcheng Taiyuan Biotechnology Co., Ltd. from Zhang Rong and others.
| | |
06/11/24 |
Northeast Pharmaceutical Group Acquiring 70% Stake in Dingcheng Peptide Source; Shares Up 10%
| | |
23/10/24 |
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024
| | |
27/08/24 |
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024
| | |
06/08/24 |
Northeast Pharmaceutical Group Co., Ltd. entered into Equity Acquisition Framework Agreement to acquire 70% stake in Beijing Dingcheng Taiyuan Biotechnology Co., Ltd. from Zhang Rong and others.
| |
Aucun résultat pour cette recherche Sélectionnez votre édition Toutes les informations financières adaptées au niveau national | 
